Glaxosmithkline Llc Pac (Gsk Pac) FEB MONTHLY Filings

Cycle Date Filed End Date Amendment Receipts Spending Cash
2024 Feb. 20 Jan. 31 $23,225.35 $77.17 $49,317.34
2024 Feb. 15, 2023 Jan. 31, 2023 $22,666.73 $107.65 $64,856.10
2022 March 17, 2022 Jan. 31, 2022 Compare to original $24,412.30 $80.37 $142,640.71
2022 Feb. 5, 2021 Jan. 31, 2021 $24,478.32 -$21,669.21 $136,390.24
2020 Feb. 11, 2020 Jan. 31, 2020 $24,995.06 $9,132.38 $182,261.40
2020 Feb. 20, 2019 Jan. 31, 2019 $27,942.18 $2,606.70 $148,055.15
2018 Feb. 20, 2018 Jan. 31, 2018 $32,460.17 $242.94 $120,678.09
2018 Feb. 20, 2017 Jan. 31, 2017 $31,034.31 $222.31 $114,605.57
2016 Feb. 19, 2016 Jan. 31, 2016 $45,801.31 $402.75 $173,572.96
2016 Feb. 20, 2015 Jan. 31, 2015 $59,858.01 $143.79 $196,355.31
2014 Feb. 19, 2014 Jan. 31, 2014 $63,154.28 -$300.42 $185,130.28
2014 Feb. 19, 2013 Jan. 31, 2013 $42,300.31 $1,287.27 $113,120.69
2012 Feb. 20, 2012 Jan. 31, 2012 $42,846.65 -$3,687.60 $117,969.02
2012 Feb. 15, 2011 Jan. 31, 2011 $46,145.15 $3,295.44 $148,147.50
2010 Feb. 18, 2010 Jan. 31, 2010 $63,551.09 $5,119.11 $197,621.09
2010 Sept. 18, 2009 Jan. 31, 2009 Compare to original $72,000.15 $5,262.34 $176,410.37
2008 Sept. 18, 2009 Jan. 31, 2008 Compare to original $75,815.00 $57,380.00 $157,577.00
2008 Feb. 20, 2007 Jan. 31, 2007 $77,926.36 $26,792.86 $203,583.88
2006 Sept. 28, 2006 Jan. 31, 2006 Compare to original $81,415.76 $12,355.00 $534,615.02
2006 Feb. 16, 2005 Jan. 31, 2005 $83,183.50 $38,500.00 $278,714.00
2004 Feb. 19, 2004 Jan. 31, 2004 $116,875.00 $3,825.00 $396,843.00
2004 Feb. 14, 2003 Jan. 31, 2003 View View
2002 March 19, 2002 Jan. 31, 2002 View View
2002 Feb. 14, 2001 Jan. 31, 2001 View View